Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide vs Levocetirizine in Allergic Rhinitis
NCT01430260Phase 4Completed
- Sponsor
- Handok
- Start
- Jan 2011
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ciclesonide in allergic rhinitis (AR), sponsored by Handok. Started Jan 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01430260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430260.